Biora Therapeutics, Inc.
TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IMMUNE MODULATORY AGENT RELEASED USING AN INGESTIBLE DEVICE

Last updated:

Abstract:

This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an immune modulatory agent (e.g., a CD40/CD40L inhibitor).

Status:
Application
Type:

Utility

Filling date:

30 Mar 2018

Issue date:

13 May 2021